Objective To test anti-Sa antibody in different autoimmune connective
tissue diseases and analyze the relationship between Sa antibody and c
linical manifestations and laboratory tests in rheumatoid arthritis. M
ethod Sa antigen was extracted from human placenta. Anti-Sa antibody w
as tested in 40 normal people and 478 connective tissue disease (CTD)
patients using Western Blotting (WE). Results Sa antigen was a protein
with molecular weights of 50 kD and 55 kD. Anti-Sa antibody was posit
ive in 31.9% (61/191) rheumatoid arthritis (RA), 3.0% (2/67) Sjogren's
syndrome (SS), 4.3% (2/46) systemic lupus erythmatosus (SLE) and 0% (
0/66) Behcet's disease, 0% (0/60) polymyositis/dermatomyositis (PM/DM)
, 0%(0/66) other CTD and 0% (0/40) normal controls. Anti-Sa antibody w
as different from other auto-antibodies in RA. In rheumatoid arthritis
its sensitivity, specificity, positive prediction rate, negative pred
iction rate were 31.9%, 98.6%, 93.8% and 68.5% respectively. Anti-Sa a
ntibody positive patients were significantly different from anti-Sa an
tibody negative patients in morning stiffness, ESR, ANA and X-ray grad
e. Conclusion Anti-Sa antibody was a new autoantibody for the diagnosi
s of RA. Anti-Sa antibody positive patients seem to have more serious
inflammation and more advanced disease process.